期刊文献+

1例泛耐药鲍曼不动杆菌肺部感染患者临床治疗的药学监护及抗菌药物的使用分析 被引量:3

Pharmaceutical Care for Anti-infection Medication in A Pulmonary infection Patient with Pan-resistant Acinetobacter baumannii
在线阅读 下载PDF
导出
摘要 目的:分析鲍曼不动杆菌感染患者临床治疗的药学监护及抗菌药物合理使用。方法:临床药师对1例泛耐药鲍曼不动杆菌肺部感染患者的治疗过程进行全程监护,分析抗菌药物的合理使用。结果:该患者鲍曼不动杆菌定植与感染交替存在,对于鲍曼不动杆菌感染时,按《抗菌药物临床应用指导原则》要求联合用药治疗;要提高免疫力,加强防治。结论:鲍曼不动杆菌的定植和感染的区分仍是临床上的难点,需结合患者临床症状和检验指标判断,临床药师可参与患者个体化用药方案的制订以保证患者的用药安全、有效。 Objective: To analyze the pharmaceutical care for anti-infection medication in pulmonary infection pa- tient with pan-resistant Acinetobacter baumannii. Methods: The entire treatments of a case of pulmonary infected by pan-resistant Acinetobacter baumannii were monitored by clinical pharmacists, and the uses of antibiotics were ana- lyzed. Results: Colonization and infection ofAcinetobacter haumannii were alternately found in the patient. For Acinetobacter haumannii infections, combination therapy is required according to "Clinical use of antihiotics guidelines". For colonization, the key measure is to improve immunity to strengthen prevention. Conclusion: The distinction be- tween colonization and infection ofAcinetohacter baumannii is still a clinical nodus, which should be determined by combining clinical symptoms and laboratory indicators. The joint of clinical pharmacists in thc development of individu- alized treatment programs would improve the safety and effectiveness of the treatment.
机构地区 勐腊县人民医院
出处 《抗感染药学》 2016年第5期1060-1063,共4页 Anti-infection Pharmacy
关键词 鲍曼不动杆菌 泛耐药 定植 感染 Acinetobacter baumannii pan-resistan colonization: infection
  • 相关文献

参考文献6

二级参考文献56

  • 1周颖杰,李光辉.成人及儿童复杂性腹腔内感染的诊断与处理:美国外科感染学会及美国感染病学会指南[J].中国感染与化疗杂志,2010,10(4):241-247. 被引量:244
  • 2韩黎,朱士俊,郭燕红,李六亿,胡必杰,武迎宏,袁云娥.中国医务人员执行手卫生的现状调查[J].中华医院感染学杂志,2006,16(2):140-142. 被引量:631
  • 3郭丽萍,李双英.手卫生规范化管理[J].中华医院感染学杂志,2006,16(6):607-607. 被引量:17
  • 4刘灿兰,刘红.医护人员洗手依从性与控制医院感染相关研究[J].中华医院感染学杂志,2006,16(8):909-911. 被引量:131
  • 5Karageorgopoulos DE, Falagas ME. Current control and treatment of multidrug-rcsistant Acinetobacter baumannii infections. Lancet Infect Dis, 2008,8:751-762.
  • 6Peleg AY, Seifert H, Paterson DL. Aeinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev, 2008, 21:538-582.
  • 7Corbella X, Ariza J, Ardanuy C, et al. Effieaey of sulbactam alone and in combination with ampieillin in nosoeomial infections caused by muhiresistant Aeinetobaeter baumannii. J AntimicrobChemother, 1998,42 z793-802.
  • 8汪复 朱德妹 胡付品.2008年巾同CHINET细菌耐药件监测[J].中同感染与化疗杂志,2009,:321-329.
  • 9Sader HS, Jones RN. Comprehensive in vitro evaluation of cefepime combined with aztreonam or ampicillin/sulbaetam against multi-drug resistant Pseudomonas aeruginosa and Aeinetobacterspp. lnt J Antimierob Agents, 2005,25:380-384.
  • 10Savoy E, Chankova D, Vateheva R, et al. In vitro investigation of the susceptibility of Acinetobacter baumannii strains isolated from clinical specimens to ampicillin/sulbactam alone and incombination with amikacin. Int J Antimicrob Agents, 2002,20: 390-392.

共引文献1530

同被引文献31

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部